Live news related to VALBIOTIS stock (FR0013254851): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The latest financial news on VALBIOTIS mainly cover M&A activity, analyst notes et earnings publications. The stock trades at €0,91 on Euronext Paris, down 2,16% at the last update. This page lists the articles published on VALBIOTIS stock to track the share price, company announcements and any item likely to influence market perception.
Valbiotis stock significantly suffers midday, penalized by investors following the announcement of a dilutive capital increase. The company is simulta…
Valbiotis announced on Monday the launch of a capital increase of €10.2 million, including the maintenance of the preferential subscription right (DPS…
Valbiotis announced on Monday the signing of an exclusive distribution agreement with Al Danah Medical Company to market its products in Qatar. This n…
Valbiotis shares are soaring in mid-session trading, continuing the momentum triggered by the European vote on monacolins from red yeast rice. The ses…
Member states of the European Union have voted in favor of a draft regulation to ban monacolins derived from red yeast rice in dietary supplements. Ac…
On Tuesday, March 31st, Valbiotis shares exhibited a significant increase, rising by 5.92% to 1.038 euros during the session. This rebound follows a s…
Valbiotis stock is experiencing a strong increase this Tuesday at midday, rising by 5.66% to €1.046. This acceleration is part of an upward trend that…
The French laboratory specializing in dietary supplements reported a revenue of €905K in 2025, a 417% increase year-over-year, while drastically reduc…
This Thursday morning, Valbiotis shows an increase of 3.35%, bringing its price to 1.05 euros. The biotech company from Clermont has been on a seven-w…
Portzamparc ajuste sa position sur Valbiotis ce mercredi 28 janvier 2026.
